|
Originally published In Press as doi:10.1074/jbc.M603845200 on September 13, 2006
J. Biol. Chem., Vol. 281, Issue 46, 34785-34795, November 17, 2006
Mutant Huntingtin Expression Induces Mitochondrial Calcium Handling Defects in Clonal Striatal Cells
FUNCTIONAL CONSEQUENCES*
Tamara Milakovic,
Rodrigo A. Quintanilla, and
Gail V. W. Johnson1
From the
Department of Psychiatry, University of Alabama at Birmingham, Birmingham, Alabama 35294
Huntington disease (HD) is caused by a pathological elongation of CAG repeats in the huntingtin protein gene and is characterized by atrophy and neuronal loss primarily in the striatum. Mitochondrial dysfunction and impaired Ca2+ homeostasis in HD have been suggested previously. Here, we elucidate the effects of Ca2+ on mitochondria from the wild type (STHdhQ7/Q7) and mutant (STHdhQ111/Q111) huntingtin-expressing cells of striatal origin. When treated with increasing Ca2+ concentrations, mitochondria from mutant huntingtin-expressing cells showed enhanced sensitivity to Ca2+, as they were more sensitive to Ca2+-induced decreases in state 3 respiration and  m, than mitochondria from wild type cells. Further, mutant huntingtin-expressing cells had a reduced mitochondrial Ca2+ uptake capacity in comparison with wild type cells. Decreases in state 3 respiration were associated with increased mitochondrial membrane permeability. The  m defect was attenuated in the presence of ADP and the decreases in Ca2+ uptake capacity were abolished in the presence of Permeability Transition Pore (PTP) inhibitors. These findings clearly indicate that mutant huntingtin-expressing cells have mitochondrial Ca2+ handling defects that result in respiratory deficits and that the increased sensitivity to Ca2+ induced mitochondrial permeabilization maybe a contributing mechanism to the mitochondrial dysfunction in HD.
Received for publication, April 21, 2006
, and in revised form, August 2, 2006.
* This study was supported by National Institutes of Health Grant NS041744. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
1 To whom correspondence should be addressed: Dept. of Psychiatry, 1720 7th Ave. South, SC 1061, University of Alabama at Birmingham, Birmingham, AL 35294-0017. Tel.: 205-934-2465; Fax: 205-934-3709; E-mail: gvwj{at}uab.edu.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
R. A. Quintanilla, T. A. Matthews-Roberson, P. J. Dolan, and G. V. W. Johnson
Caspase-cleaved Tau Expression Induces Mitochondrial Dysfunction in Immortalized Cortical Neurons: IMPLICATIONS FOR THE PATHOGENESIS OF ALZHEIMER DISEASE
J. Biol. Chem.,
July 10, 2009;
284(28):
18754 - 18766.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. N. Gellerich, Z. Gizatullina, H. P. Nguyen, S. Trumbeckaite, S. Vielhaber, E. Seppet, S. Zierz, B. Landwehrmeyer, O. Riess, S. von Horsten, et al.
Impaired Regulation of Brain Mitochondria by Extramitochondrial Ca2+ in Transgenic Huntington Disease Rats
J. Biol. Chem.,
November 7, 2008;
283(45):
30715 - 30724.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. A. Quintanilla, Y. N. Jin, K. Fuenzalida, M. Bronfman, and G. V. W. Johnson
Rosiglitazone Treatment Prevents Mitochondrial Dysfunction in Mutant Huntingtin-expressing Cells: POSSIBLE ROLE OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-{gamma} (PPAR{gamma}) IN THE PATHOGENESIS OF HUNTINGTON DISEASE
J. Biol. Chem.,
September 12, 2008;
283(37):
25628 - 25637.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Lim, L. Fedrizzi, M. Tartari, C. Zuccato, E. Cattaneo, M. Brini, and E. Carafoli
Calcium Homeostasis and Mitochondrial Dysfunction in Striatal Neurons of Huntington Disease
J. Biol. Chem.,
February 29, 2008;
283(9):
5780 - 5789.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2006 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|